Agra, Sept 17 (ANI): Hundreds of people here took part in ‘Ram Baraat’, which is a part of the Ramlila celebrations.
Jeetander Chauhan, a worker, who erected the decorations for the celebrations, said that people were happy that god was among them.
“We are feeling that Lord Ram has appeared among us. Hundreds of people have come to witness this famous god’s marriage,” said Chauhan.
Maya Sharma, a devotee, said that women were also excited about this deity marriage.
“I’m really feeling good that ‘Baraat’ procession of Lord Rama and Sita is taking place. We are feeling good that god himself is present here,” said Sharma.
Every year, a new locality is chosen in Agra and festivities last for three days and the area is elaborately decorated with lights and flowers. The area is given a major face-lift befitting the venue for the divine marriage.
The marriage procession sees marriage between saint Shaligram who represents Lord Ram and holy Basil plant, which represents Sita, his wife.
The place is lit up with thousands of lights and non-stop music. The cinema theatres run film shows throughout the night to accommodate the migratory crowd.
These three days are like a carnival when people from all walks of life come together to have a great time.
The history of Ram Baraat is said to be around 125 years old, when Lala Kokamal, a cloth merchant, started the tradition of three-day festivities, revolving around the royal wedding. (ANI)

Sanofi, Piramal proposed merger deal falls through – report
A proposed deal by France’s Sanofi-Aventis to buy a majority stake in Indian drug maker Piramal Healthcare Ltd has fallen through due to differences over valuation, a newspaper reported on Monday.
In Februray, a source familiar with the situation had told Reuters that GlaxoSmithKline Plc and Sanofi-Aventis were bidding for the Indian drug maker, with the sale price perhaps going as high as $1.5 billion.
Mumbai-based Piramal has repeatedly denied acquisition reports, calling them ‘unfounded’, and has said the founder has no intention of diluting current ownership levels.
“Sanofi Aventis had put a valuation of over 300 rupees per share for Piramal Healthcare. But, this price was not acceptable to the promoters,” The Economic Times newspaper quoted a merchant banker familiar with the development as saying.
Talks between the two companies had reached an advanced stage before it collapsed, the paper said, citing another senior pharma industry official briefed about the proposed deal.
A Piramal spokesman declined comment while Sanofi-Aventis officials could not be reached for comments immediately.